With a GDP of more than $8 trillion, China is poised to become the world’s third-largest pharmaceutical market by 2013. Accurate forecasting is essential for companies who want to break into China, in order to successfully meet potential demand and supply for products - but it is beset with unique challenges. Complexities within the China market make quality forecasting extremely challenging. But without that forecasting, U.S. companies will find themselves limited in what they can achieve in China, and leave companies vulnerable either to unmet demand or oversupply. 

At PHARMA MARKET FORECASTING FOR CHINA, we have gathered industry leaders with renowned expertise in forecasting market access, acquiring quality data, and consumer segmentation. Participants will share best practices and brainstorm strategies to tackle the complexities in the heart of China forecasting.